Comparison |
| Analyzer Type |
Benchtop | Benchtop | Benchtop | Benchtop | Handheld |
| CLIA Classification |
CLIA Waived | | | CLIA Waived for Swab Samples | CLIA Waived |
| CLIA Classified |
CLIA Waived | CLIA Waived | | CLIA Waived | CLIA Waived |
| Contents 1 |
Alere™ Reader, Barcode Scanner, Alere Binaxnow® Tray Pack, Calibration Check Card Pack, Alere™ USB Drive | | | Acucy Reader, Acucy Printer, Acucy Calibration Device, (2) AC/DC Power Converters, Exclusive USB Memory Drive, Acucy System Manual, Printer Roll, Master Password Card | Cue Reader, Power Adaptor, Power Cord |
| Country of Origin |
Japan | Unknown | Unknown | Japan | Unknown |
| Dimensions |
125 X 160 X 195 mm | 73 X 97 X 210 mm | 73 X 97 X 210 mm | 120 X 145 X 235 mm (Reader) | 1-1/2 X 2-7/8 X 2-7/8 Inch |
| For Use With |
For Alere™ Reader | For use with LumiraDx Test Strips / LumiraDx Connect | | | For use with Cue Cartridges and Cue Health App on a Mobile Smart Device |
| Number of Tests |
22 Tests | | | | |
| Power Source |
100 to 240 VAC, 50/60 Hz | 100 to 240V, 50/60Hz | 100 to 240V, 50/60Hz | 100 to 240 V, 50/60 Hz | Rechargeable Battery |
| Product Dating |
| | | McKesson Acceptable Dating: we will ship >= 90 days | |
| Purchase Program Type |
Standard Purchase Agreement | Standard Purchase Agreement | Promotional Bundle | Standard Purchase Agreement | Standard Purchase Agreement |
| Readout Type |
Touch Screen, Printout | Touchscreen Display | Touchscreen Display | USB Data Transfer / Printout | |
| Sample Type |
Nasal Swab / Nasopharyngeal Swab | Capillary Blood Sample / Nasal Swab Sample | Capillary Blood Sample / Nasal Swab Sample | Nasal Swab / Nasopharyngeal Swab | Nasal Swab Sample |
| Test Name |
Influenza A + B Test | SARS-CoV-2 Ag, SARS-CoV-2 Ab, D-Dimer, Prothrombin Time (INR), Surveillance | | Influenza A + B Test | COVID-19 |
| Time to Results |
15 Minute Results | | | 15 Minute Results | 20 Minute Results |
| UNSPSC Code |
41115808 | 41115819 | 41115808 | 41115800 | 41115800 |
| User Interface |
4-1/3 Inch Touch Screen | High Contrast Touch Screen / Barcode Scanner | High Contrast Touch Screen / Barcode Scanner | LCD Touch Screen | |
| Weight |
3.3 lbs | 2.42 lbs. | 2.42 lbs. | 1.7 kg (Reader) | 5.3 oz. |
| Application |
Respiratory Test Reader | Respiratory Test Reader | Respiratory Test Reader | Respiratory Test Reader | Respiratory Test Reader |
| Features and Benefits |
- Alere BinaxNOW® Influenza A & B Card 2 is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab and nasal swab samples
- Alere BinaxNOW® Influenza A & B Card 2 must be read by the Alere™ Reader
- The first rapid antigen influenza test to achieve 510(k) clearance as a Class II assay under the new FDA Reclassification performance requirements
|
- The LumiraDx Platform is an innovative, next generation point of care system that combines a small, portable instrument, advanced low cost test strip and seamless digital connectivity
- Enzyme and immunoassay on a single platform
- Its proprietary technology enables it to deliver exceptional point of care clinical performance, while being simple and easy to use
- Performance referenced to laboratory test
- Portable instrument, seamless connectivit
- One simple, intuitive test workfow
- Fast results in minutes
- All common clinical samples
- Small sample size including capillary blood
- Ability to perform Quality Control Tests using LumiraDx Quality Control to meet regulatory compliance requirements
- 2 x USB ports, RFID reader 13.56 MHz, 0 dBi (EIRP), Bluetooth low-energy 2.4 GHz ISM band, 2400 MHz to 2483.5 MHz, 0.5 dBm (ERP)
- Lithium ion polymer 7.4 V 5000 mAh battery
- High contrast touchscreen with a wide viewing angle
- Uses small sample volumes and multiple convenient sample types, including nasal swab and capillary blood
- Pipeline of 30+ assays, initially focused on some of the most common conditions being diagnosed or managed with POC testing
- The LumiraDx SARS-CoV-2 Ag Test has been authorized by FDA under an EUA only for the detection of SARS-CoV-2 nucleocapsid protein
- The LumiraDx SARS-CoV-2 Ab Test has been authorized by FDA under an EUA only for detecting the presence of total antibodies to SARS-CoV-2
|
- LumiraDx TOP Program Starter Pack (7 Kits), Includes Instrument, Kits, Controls, Swabs
|
- Innovative Composite Comparator with molecular and culture
- Read Now or Walk Away mode
- Results within 15 minutes
- The Acucy Reader is an optoelectronic instrument that uses a reflectance-based measurement method to evaluate the line signal intensities on the test strip, and a specific algorithm to determine the presence or absence of any target analyte(s)
|
- Cue Reader is a durable, intuitive automated processor of test results and is used with Cue tests and the Cue Health App - designed to work with Cue's COVID-19 tests as well as future tests
- The Cue Reader runs single-use cartridges and communicates the result of the test digitally via Bluetooth® to the Cue Health App
- The Cue Cartridge Reader features 5 LED indicator lights located on the top of the Cue Cartridge Reader
- Once the Cue Wand with the nasal sample is inserted into the pre-heated Cue Test Cartridge, the Cue Reader will process the test and communicate the result directly to the Cue Health App on your mobile device via Bluetooth®
- The lights provide quick feedback on the status of the Cue Cartridge Reader together with the Cue Health App
- Cue is the first compact, portable molecular self-testing system authorized by the FDA for use at home or on the go, without a prescription
- Cue COVID-19 tests sold separately
|
